価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
GDF-15, Human, Recombinant <MIC-1>
データシート
957-GD-025 RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥89,000 1個 追加

在庫・価格 : 2025年04月29日 23時55分 現在

GDF-15, Human, Recombinant <MIC-1>

  • 商品コード:957-GD-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥89,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Wollmann W et al. The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis 2005 May;26(5):900-7
Wollmann W et al
2005/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
2 Wollert KC et al. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007 Feb;115(8):962-71
Wollert KC et al
2007/01/01
Species: Human, Application: ELISA Standard, Sample type: Plasma (Citrate), Serum PubMed
3 Tanno T et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 2007 Sep;13(9):1096-101
Tanno T et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
4 Kim KK et al. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 2008 Apr;29(4):704-12
Kim KK et al
2008/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
5 Strelau J et al. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines. Cancer Lett. 2008 Oct;270(1):30-9
Strelau J et al
2008/01/01
Application: ELISA Standard, Sample Type: Cell Supernates PubMed
6 Ding Q et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 2009 Apr;150(4):1688-96
Ding Q et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Khan SQ et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur. Heart J. 2009 May;30(9):1057-65
Khan SQ et al
2009/01/01
Application: ELISA Development, Sample Type: Plasma (EDTA) PubMed
8 Foley PW et al. Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur. Heart J. 2009 Nov;30(22):2749-57
Foley PW et al
2009/01/01
Application: ELISA Standard, Sample Type: Plasma (Not Specified) PubMed
9 Zhao L et al. Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. Cancer Res. 2009 Oct;69(19):7696-703
Zhao L et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
10 Strelau J et al. Progressive postnatal motoneuron loss in mice lacking GDF-15. J. Neurosci. 2009 Oct;29(43):13640-8
Strelau J et al
2009/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
11 Huh SJ et al. Macrophage inhibitory cytokine-1 regulates melanoma vascular development. Am. J. Pathol. 2010 Jun;176(6):2948-57
Huh SJ et al
2010/01/01
Application: Bioassay, Sample Type: In Vivo PubMed
12 Schledzewski K et al. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin. Invest. 2011 Feb;121(2):703-14
Schledzewski K et al
2011/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
13 Cheng JC et al. Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. Endocrinology 2011 Aug;152(8):2987-95
Cheng JC et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Si Y et al. Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS ONE 2011;6(5):e19967
Si Y et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
15 Castonguay R et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J. Biol. Chem. 2011 Aug;286(34):30034-46
Castonguay R et al
2011/01/01
Application: Surface Plasmon Resonance, Sample Type: recombinant Endoglin PubMed
16 Kempf T et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ. Res. 2006 Feb;98(3):351-60
Kempf T et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
17 Rossaint J et al. GDF-15 prevents platelet integrin activation and thrombus formation. J. Thromb. Haemost. 2013 Feb;11(2):335-44
Rossaint J et al
2013/01/01
Application: Bioassay, Sample Type: In Vivo PubMed
18 Mimeault M et al. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. Br. J. Cancer 2013 Mar;108(5):1079-91
Mimeault M et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
19 Zhou Z et al. Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response. PLoS ONE 2013;8(11):e78618
Zhou Z et al
2013/01/01
Application: Bioassay, Sample Type: whole cells PubMed
20 Li J et al. Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer. PLoS ONE 2015;10(4):e0122249
Li J et al
2015/01/01
Application: Antigen, Sample Type: Serum PubMed
21 Li YL et al. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway. Oncotarget 2017 Jan;8(1):1508-1528
Li YL et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
22 Muralidharan AR et al. Growth Differentiation Factor-15-Induced Contractile Activity and Extracellular Matrix Production in Human Trabecular Meshwork Cells. Invest. Ophthalmol. Vis. Sci. 2016 Dec;57(15):6482-6495
Muralidharan AR et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Wollmann W et al. The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis 2005 May;26(5):900-7
    Wollmann W et al
    2005/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wollert KC et al. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007 Feb;115(8):962-71
    Wollert KC et al
    2007/01/01
  • 備考:
    Species: Human, Application: ELISA Standard, Sample type: Plasma (Citrate), Serum
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Tanno T et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 2007 Sep;13(9):1096-101
    Tanno T et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kim KK et al. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 2008 Apr;29(4):704-12
    Kim KK et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Strelau J et al. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines. Cancer Lett. 2008 Oct;270(1):30-9
    Strelau J et al
    2008/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ding Q et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 2009 Apr;150(4):1688-96
    Ding Q et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Khan SQ et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur. Heart J. 2009 May;30(9):1057-65
    Khan SQ et al
    2009/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Foley PW et al. Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur. Heart J. 2009 Nov;30(22):2749-57
    Foley PW et al
    2009/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Zhao L et al. Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. Cancer Res. 2009 Oct;69(19):7696-703
    Zhao L et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Strelau J et al. Progressive postnatal motoneuron loss in mice lacking GDF-15. J. Neurosci. 2009 Oct;29(43):13640-8
    Strelau J et al
    2009/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Huh SJ et al. Macrophage inhibitory cytokine-1 regulates melanoma vascular development. Am. J. Pathol. 2010 Jun;176(6):2948-57
    Huh SJ et al
    2010/01/01
  • 備考:
    Application: Bioassay, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Schledzewski K et al. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin. Invest. 2011 Feb;121(2):703-14
    Schledzewski K et al
    2011/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Cheng JC et al. Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. Endocrinology 2011 Aug;152(8):2987-95
    Cheng JC et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Si Y et al. Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS ONE 2011;6(5):e19967
    Si Y et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Castonguay R et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J. Biol. Chem. 2011 Aug;286(34):30034-46
    Castonguay R et al
    2011/01/01
  • 備考:
    Application: Surface Plasmon Resonance, Sample Type: recombinant Endoglin
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kempf T et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ. Res. 2006 Feb;98(3):351-60
    Kempf T et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Rossaint J et al. GDF-15 prevents platelet integrin activation and thrombus formation. J. Thromb. Haemost. 2013 Feb;11(2):335-44
    Rossaint J et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Mimeault M et al. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. Br. J. Cancer 2013 Mar;108(5):1079-91
    Mimeault M et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Zhou Z et al. Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response. PLoS ONE 2013;8(11):e78618
    Zhou Z et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Li J et al. Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer. PLoS ONE 2015;10(4):e0122249
    Li J et al
    2015/01/01
  • 備考:
    Application: Antigen, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Li YL et al. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway. Oncotarget 2017 Jan;8(1):1508-1528
    Li YL et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Muralidharan AR et al. Growth Differentiation Factor-15-Induced Contractile Activity and Extracellular Matrix Production in Human Trabecular Meshwork Cells. Invest. Ophthalmol. Vis. Sci. 2016 Dec;57(15):6482-6495
    Muralidharan AR et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed